Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ESMO 2025 Recap: Top 13 Trials in Genitourinary Oncology

Summary by urologytimes.com
Take a look through the top readouts in urologic oncology from ESMO 2025.

8 Articles

Globe NewswireGlobe Newswire
+6 Reposted by 6 other sources
Center

Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

TORONTO and HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a...

Read Full Article
urologytimes.comurologytimes.com

ESMO 2025 recap: Top 13 trials in genitourinary oncology

Take a look through the top readouts in urologic oncology from ESMO 2025.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources lean Left
57% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cambridge Times broke the news in Cambridge, Canada on Thursday, October 23, 2025.
Sources are mostly out of (0)

Similar News Topics

Toronto, ON icon

Toronto, ON

News
For You
SearchBlindspotLocal